<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Diagn Pathol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Diagn Pathol</journal-id>
      <journal-title-group>
        <journal-title>Diagnostic Pathology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1746-1596</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27142509</article-id>
      <article-id pub-id-type="pmc">4855418</article-id>
      <article-id pub-id-type="publisher-id">493</article-id>
      <article-id pub-id-type="doi">10.1186/s13000-016-0493-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Diagnostic dilemma of IgG4-related primary localized cervical lymphadenopathy associated with aberrant IL-6 expression level</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Nakamura</surname>
            <given-names>Moriyoshi</given-names>
          </name>
          <address>
            <email>nakamura_moriyoshi@kurume-u.ac.jp</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Iwamoto</surname>
            <given-names>Osamu</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Chino</surname>
            <given-names>Takahiro</given-names>
          </name>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Todoroki</surname>
            <given-names>Keita</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kusukawa</surname>
            <given-names>Jingo</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1"><label/>Dental and Oral Medical Center, Kurume University School of Medicine, 67 Asahi-machi, Kurume, 830-0011 Japan </aff>
        <aff id="Aff2"><label/>Department of Biomedical Sciences, University of the Pacific, Arthur A. Dugoni School of Dentistry, 155 fifth St, San Francisco, CA 94103 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>3</day>
        <month>5</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>3</day>
        <month>5</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>11</volume>
      <elocation-id>43</elocation-id>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>1</month>
          <year>2016</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>4</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Nakamura et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Immunoglobulin G4-related disease (IgG4-RD) is a recently recognized inflammatory condition with single- or multi-organ involvement. The disease is characterized by tumefactive lesions with dense IgG4 plasmacytic infiltration (an elevated IgG4<sup>+</sup>/IgG<sup>+</sup> cell ratio of&#x2009;&gt;&#x2009;40&#xA0;%), storiform fibrosis, and obliterative phlebitis, with or without elevated serum IgG4 levels. The diagnostic criteria for IgG4-RD, proposed in 2011, were quite comprehensive and practical; however, it is important to remember that other diseases, such as hyper-interleukin (IL)-6 syndromes, may have common histopathological findings. Therefore, the histopathology of suspected IgG4-RD is occasionally not diagnostic. Here, we report a case of IgG4-related primary localized cervical lymphadenopathy without any other organ involvement. To our knowledge, there have been no previous reports of this. Additionally, the disease was associated with a 20-fold increase in IL-6 levels compared to that of the normal range.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We report the case of a 52-year-old Japanese man who presented with a painless, somewhat diffuse swelling in the left submandibular region. Although the case fulfilled diagnostic criteria for IgG4-RD, the diagnosis was not straightforward due to abnormally high levels of serum IL-6. After systematic evaluation of the patient, a final diagnosis of IgG4-RD was established. Since then, a specialist in connective tissue disorders has evaluated the patient on a regular basis. Two years after his initial visit, no disease progress or systemic involvement has been noted.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>We present a case of an IgG4-related primary localized cervical lymphadenopathy mimicking hyper-IL-6 syndrome. This case can serve as an excellent reminder that the definitive diagnosis of IgG4-RD should be established using a systematic approach, in particular when it appears as an atypical manifestation.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>IgG4</kwd>
        <kwd>IgG4-related disease</kwd>
        <kwd>Lymphadenopathy</kwd>
        <kwd>IL-6</kwd>
        <kwd>Castleman&#x2019;s disease</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Swellings of the cervical area are often associated with congenital or acquired conditions including cystic, inflammatory, infectious, and neoplastic diseases. Thus, the differential diagnosis of diseases involving cervical swelling is quite extensive. Immunoglobulin G4-related disease (IgG4-RD) is a recently recognized inflammatory condition that has single- or multi-organ involvement. The head and neck region is the second most common site for the development of IgG4-RD. The disease is characterized by tumefactive lesions with dense IgG4 plasmacytic infiltration (an elevated IgG4<sup>+</sup>/IgG<sup>+</sup> cell ratio of&#x2009;&gt;&#x2009;40&#xA0;%, and&#x2009;&gt;&#x2009;10 IgG4<sup>+</sup> cells per high power field), storiform fibrosis, and obliterative phlebitis with or without elevated serum IgG4 levels [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref>]. The presence of these three histopathological findings, as well as the increased number and ratio of IgG4<sup>+</sup> plasma cells, is highly suggestive of a diagnosis of IgG4-RD [<xref ref-type="bibr" rid="CR4">4</xref>]. Although lymphadenopathy is frequently associated with IgG4-RD, it usually lacks storiform fibrosis, and its histopathological findings are further divided into five types. These include multicentric Castleman&#x2019;s disease-like (type I), reactive follicular hyperplasia-like (type II), interfollicular expansion and immunoblastosis (type III), progressively transformed germinal center (PTGC) type (type IV), and inflammatory pseudotumor like (type V) IgG4-related lymphadenopathy [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
      <p>Increased numbers of IgG4<sup>+</sup> plasma cells might be associated with non-IgG4-RD, such as low-grade B-cell lymphomas and hyper-interleukin (IL)-6 syndromes, such as Castleman&#x2019;s disease [<xref ref-type="bibr" rid="CR6">6</xref>] and rheumatoid arthritis [<xref ref-type="bibr" rid="CR7">7</xref>], all of which can result in cervical lymphadenopathy. Since histopathological findings of such diseases are occasionally similar to that of IgG4-RD, Sato and Yoshino [<xref ref-type="bibr" rid="CR5">5</xref>] proposed that the combination of histological examination and laboratory analyses are essential for the definitive diagnosis of the disease.</p>
      <p>Here, we report a case of IgG4-related primary localized cervical lymphadenopathy without any other organ involvement. To our knowledge, there have been no previous reports of this. In addition, the disease was associated with 20-fold higher IL-6 levels than those of the normal range.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 52-year-old Japanese male with no significant past medical history visited our clinic in 2013 for evaluation of a swelling in the left submandibular region, which had increased in size over four years. The patient had not experienced any symptomatic manifestations.</p>
      <p>Extraoral examination revealed a 40&#x2009;&#xD7;&#x2009;20&#xA0;mm mass in his left submandibular region that was elastically hard, movable, painless, and covered with normal skin (Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1</xref>). Intraoral examination revealed an appropriate salivary flow, and therefore, the patient was not xerostomic. A computed tomography (CT) scan revealed a 35&#x2009;&#xD7;&#x2009;23&#xA0;mm oval swelling in the left submandibular region associated with enlarged submental lymph nodes and superior internal jugular area, in which contrast medium was taken up homogenously (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2a</xref>). Contrast-enhanced T1<bold>-</bold>weighted magnetic resonance imaging (MRI) demonstrated enlarged submandibular and submental lymph nodes and ipsilateral upper internal jugular vein (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2b</xref>). Additionally, in T2 weighted MRI, they structures were hypointense. Positron emission tomography (PET) revealed abnormal accumulation of fluorodeoxyglucose (FDG) in the left submandibular and left upper internal jugular regions. The FDG-standardized uptake value (SUV) max values were 5.09&#x2013;8.24 for the left submandibular and 2.82&#x2013;3.19 for the left upper internal jugular area. No clear abnormal accumulation was noted in any area other than the neck region (Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2c</xref>), and laboratory tests revealed no inflammation. Furthermore, IL-2R and LDH values were normal (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). Based on clinical, imaging, and laboratory findings, the patient was diagnosed with malignant lymphoma. However, the fine needle aspiration cytology (FNAC) of the swollen lymph node failed to show signs of malignancy. Subsequent biopsy revealed lymphatic follicles with an enlarged and hyperplastic germinal center. Histiocytes, lymphocytes, and plasma cells were scattered between the follicles. Histopathological specimens also revealed a normal shape of the lymphocytic nucleus as well a normal nucleus-cytoplasmic ratio (Figs.&#xA0;<xref rid="Fig3" ref-type="fig">3a</xref> and <xref rid="Fig3" ref-type="fig">b</xref>). The specimens were immunoreactive against both CD3 and CD20 antibodies (Figs.&#xA0;<xref rid="Fig3" ref-type="fig">3c</xref> and <xref rid="Fig3" ref-type="fig">d</xref>), and were negative for the neoplastic lesion. Although reactive follicular hyperplasia is associated with pathological conditions, such as rheumatic disorders, systemic lupus erythematosus and bacterial lymphadenitis were included as differential diagnoses, as rheumatoid factor (RF), anti-DNA antibody, and C-reactive protein (CRP) values were all within the normal range (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>). However, increased serum IgG4 (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>) indicated the possibility of IgG4-related lymphadenopathy. Immunohistochemical staining against IgG and IgG4 revealed a ratio of IgG4/IgG-positive plasma cells of approximately 50&#xA0;% and&#x2009;&gt;&#x2009;10 IgG4 cells per high power field, noted in the germinal center (Figs.&#xA0;<xref rid="Fig3" ref-type="fig">3e, f</xref> and <xref rid="Fig4" ref-type="fig">4</xref>). These findings fulfilled the diagnostic criteria issued in 2011 for IgG4-related disease [<xref ref-type="bibr" rid="CR7">7</xref>], although the serum level of IL-6 was 20-fold higher than the normal value.<fig id="Fig1"><label>Fig. 1</label><caption><p>The first extraoral photograph. Extraoral examination revealed a 40&#x2009;&#xD7;&#x2009;20&#xA0;mm mass (arrowhead) in the left submandibular region that was elastically hard, movable, painless, and covered with normal skin</p></caption><graphic xlink:href="13000_2016_493_Fig1_HTML" id="MO1"/></fig><fig id="Fig2"><label>Fig. 2</label><caption><p>CT scan (<bold>a</bold>) and Contrast-enhanced T1-weighted MRI (<bold>b</bold>) revealed an oval swelling (<italic>Large arrowhead</italic>) in the left submandibular region associated with enlarged submental lymph nodes (<italic>Small arrowhead</italic>) and the superior internal jugular area. A PET (<bold>b</bold>) revealed abnormal accumulation of FDG in the left submandibular (<italic>Large arrowhead</italic>) and left upper internal jugular regions (<italic>Small arrowhead</italic>). No clear abnormal accumulation was noted in any area other than the neck region</p></caption><graphic xlink:href="13000_2016_493_Fig2_HTML" id="MO2"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Laboratory tests</p></caption><table frame="hsides" rules="groups"><thead><tr><th>General</th><th>Biochemical</th><th>Special method inspection</th></tr></thead><tbody><tr><td>WBC 5900/&#x3BC;L</td><td>AST 18 U/L</td><td>IL2R 382 U/mL</td></tr><tr><td>Neut 50.2&#xA0;%</td><td>ALT 25 U/L</td><td>CEA 2.1&#xA0;ng/mL</td></tr><tr><td>Eos 2.2&#xA0;%</td><td>LD 15 U/L 0</td><td>SCC 1.0&#xA0;ng/mL</td></tr><tr><td>Bas 0.5&#xA0;%</td><td>ALP195 U/L</td><td/></tr><tr><td>Mon 7.3&#xA0;%</td><td>r-GTP 42 U/L</td><td/></tr><tr><td>Lym 39.8&#xA0;%</td><td>TP 7.31&#xA0;g/dL</td><td/></tr><tr><td>RBC 521&#x2009;&#xD7;&#x2009;10<sup>4</sup> /&#x3BC;L</td><td>Alb 4.42&#xA0;g/dL</td><td/></tr><tr><td>Hb 16.3&#xA0;g/dL</td><td>BUN 18.2&#xA0;mg/dL</td><td/></tr><tr><td>Hct 47.2&#xA0;%</td><td>Cre 0.76&#xA0;mg/dL</td><td/></tr><tr><td>PLT 27&#x2009;&#xD7;&#x2009;10<sup>4</sup> /&#x3BC;L</td><td/><td/></tr></tbody></table></table-wrap><fig id="Fig3"><label>Fig. 3</label><caption><p>
<bold>a</bold>, <bold>b</bold> Histopathological specimens revealed lymphatic follicles (<italic>arrowhead</italic>) with an enlarged and hyperplastic germinal center. <bold>c</bold>, <bold>d</bold> The specimens were immunoreactive against both CD3 and CD20. <bold>e</bold>, <bold>f</bold> Immunohistochemical staining of IgG and IgG4 revealed a ratio of IgG4/IgG-positive plasma cells (<italic>arrowhead</italic>) of approximately 50&#xA0;% and large quantities of IgG4 were noted in the germinal center</p></caption><graphic xlink:href="13000_2016_493_Fig3_HTML" id="MO3"/></fig><table-wrap id="Tab2"><label>Table 2</label><caption><p>Laboratory tests</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>IgA221 mg/dL</td><td>RF &lt;1&#xA0;IU/mL</td></tr><tr><td>IgM 157 mg/dL</td><td>Anti SS-A/Ro antibody(-)</td></tr><tr><td>IgG 1136 mg/dL</td><td>Anti SS-B/La antibody (&#x2212;)</td></tr><tr><td>IgG4 153&#xA0;mg/dL &#x2191;</td><td>Anti DNA antibody (&#x2212;)</td></tr><tr><td>CRP 0.11&#xA0;mg/dL</td><td>Anti RNP antibody (&#x2212;)</td></tr><tr><td>IL &#x2212;6 83.5&#xA0;pg/mL &#x2191;</td><td>MPO. ANCA &lt;1.0</td></tr><tr><td/><td>PR3-ANCA &lt;1.0</td></tr></tbody></table></table-wrap><fig id="Fig4"><label>Fig. 4</label><caption><p>The mean number of IgG4+ plasma cells per high power field was 94 (original magnification 400 &#xD7;)</p></caption><graphic xlink:href="13000_2016_493_Fig4_HTML" id="MO4"/></fig></p>
      <p>Based on the final diagnosis of IgG4-related cervical lymphadenopathy (type II reactive follicular hyperplasia type), the patient was referred to the Department of Internal Medicine and Connective Tissue Disorders, Kurume University School of Medicine, two months after his initial visit. The patient has been under regular follow-up, and no disease progress or systemic involvement has been noted.</p>
    </sec>
    <sec id="Sec3">
      <title>Discussion</title>
      <p>IgG4-RD is a recently established immune-mediated, inflammatory condition that affects virtually every organ system. Lymphadenopathy, often associated with extranodal lesions, is frequently observed in patients with IgG4-RD. Lymph node involvement often occurs after or at the same time as the development of the extranodal lesion. The initial unifocal lymphadenopathy may progress to a multifocal lesion and/or develop to have extranodal involvement [<xref ref-type="bibr" rid="CR8">8</xref>]. The present case is somewhat atypical as an IgG4-RD in two aspects: 1) unifocal cervical lymphadenopathy, and 2) association of high serum IL-6.</p>
      <p>In the report by Sato et al. [<xref ref-type="bibr" rid="CR5">5</xref>], IgG4-related lymphadenopathy histologically was divided into I-V types. In many cases, in the type similar to Castleman&#x2019;s disease and ALPIBP type, lymph node swelling occurs throughout the body. However, with the reactive follicular hyperplasia type (the type similar to inflammatory pseudotumors and the PTGC-like type), most cases appear to have localized swelling of the lymph nodes. The IgG4-positive cell permeation pattern is intra-follicular in cases similar to Castleman&#x2019;s disease, the reactive follicular hyperplasia type, the ALPIBP type, and the type similar to inflammatory pseudotumors, while with the PTGC-like type, there is a greater incidence of germ center permeation. In this case, the patient experienced localized swelling of the lymph nodes, and histopathological testing revealing that the IgG4-positive plasma cells had permeated the germ center; therefore, it was initially believed to be the PTGC-like type. Despite this, the fact that the follicle structure of the germ center had been preserved indicated that there was no progressive dysplasia, although hyperplastic deformation of the large and small lymphatic follicles was noted. It was eventually determined that the condition was the reactive follicular hyperplasia type.</p>
      <p>The head and neck region, including salivary, lacrimal, thyroid, and pituitary glands is the second most common site affected by IgG4-RD [<xref ref-type="bibr" rid="CR9">9</xref>]. IgG4-RD in the head and neck region can be an extrapancreatic manifestation associated with autoimmune pancreatitis or can present as a solitary lesion. Mikulicz disease and chronic sclerosing sialadenitis, often associated with lymphadenopathy, are the most common IgG4-RDs in the head and neck area. However, the disease presented here was still localized to the cervical area with and no extranodal involvement has been noted since the patient was initially diagnosed with IgG4-RD.</p>
      <p>The diagnostic dilemma in the present case was an extremely high level of serum IL-6 since hyper-IL-6 syndromes occasionally fulfill the histopathological diagnostic criteria for IgG4-RD and have elevated serum IgG4 levels [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. A few cases of IgG4-related systemic lymphadenopathy with elevated (~9-fold) IL-6 levels have been reported [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. However, the present case was associated with a serum IL-6 level 20-fold higher than the normal range. This is the first case of IgG4-RD cervical lymphadenopathy associated with such a high level of IL-6. IL-6 was originally cloned as T cell-derived B cell activating molecule in 1986 [<xref ref-type="bibr" rid="CR11">11</xref>]. Currently, it is known as a pleiotropic cytokine playing a role in the regulation of immune system, osseous tissues, and inflammation. It also has a role as a growth factor in malignancies, such as multiple myeloma (MM) [<xref ref-type="bibr" rid="CR12">12</xref>]. The variation of IL-6 levels in individuals and/or the circadian rhythm of serum IL-6 may account for the elevated IL-6 level in the present case. It has been suggested that IL-6 values might vary widely among healthy individuals [<xref ref-type="bibr" rid="CR10">10</xref>]. In the pathological situation, patients with MM reveal elevated, normal, or undetectable serum levels of IL-6. Additionally, circadian variation of serum IL-6 has been reported in several diseases [<xref ref-type="bibr" rid="CR12">12</xref>&#x2013;<xref ref-type="bibr" rid="CR14">14</xref>].</p>
      <p>Both IgG4-RD and hyper-IL-6 syndrome share similar clinical and pathological manifestations and, therefore, it is quite difficult to differentiate them. As suggested by Sato et al. [<xref ref-type="bibr" rid="CR5">5</xref>], diagnosis of IgG4-RD must be established based on histopathological appearance as well as increased serum IgG4. However, occasional increases in serum IL-6 and IgG4 in IgG4-RD and hyper-IL-6 syndrome, respectively, make the differentiation between IgG4-RD and hyper-IL-6 syndrome more difficult. Hyper-IL-6 syndromes are rheumatoid arthritis, Sj&#xF6;gren&#x2019;s syndrome, systemic lupus erythematosus, mixed connective tissue disease, human immunodeficiency virus (HIV) infection, human herpes virus 8 (HHV8) infection, Kaposi&#x2019;s sarcoma, plasma cell dyscrasia, Hodgkin&#x2019;s lymphoma, and malignant lymphoma. In particular, the histological findings of multicentric Castleman&#x2019;s disease (MCD) and IgG4-related lymphadenopathy are often similar. MCD is a distinct type of lymphoproliferative disorder associated with inflammatory symptoms and IL-6 dysregulation. In the context of HIV infection, MCD is associated with HHV8 infection [<xref ref-type="bibr" rid="CR15">15</xref>, <xref ref-type="bibr" rid="CR16">16</xref>]. Anemia, hypoalbuminemia, hypocholesterolemia, and thrombocytosis are peculiar to hyper-IL-6 syndrome, and were not found in the present case (Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5</xref>) [<xref ref-type="bibr" rid="CR6">6</xref>]. Furthermore, we could not detect HHV8 in the lymph nodes (Fig.&#xA0;<xref rid="Fig6" ref-type="fig">6</xref>), ruling out HHV8-associated MCD.<fig id="Fig5"><label>Fig. 5</label><caption><p>Comprehensive diagnostic criteria for IgG4- related disease (modified after Umehara et al. [<xref ref-type="bibr" rid="CR2">2</xref>])</p></caption><graphic xlink:href="13000_2016_493_Fig5_HTML" id="MO5"/></fig><fig id="Fig6"><label>Fig. 6</label><caption><p>Histopathological specimens were negative for HHV-8 immunohistochemical staining (original magnification 100 &#xD7;)</p></caption><graphic xlink:href="13000_2016_493_Fig6_HTML" id="MO6"/></fig></p>
      <sec id="Sec4">
        <title>Consent</title>
        <p>Written informed consent was obtained from the patient for publication of this Case Report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
      </sec>
    </sec>
    <sec id="Sec5">
      <title>Conclusions</title>
      <p>We present a case of an IgG4-related primary localized cervical lymphadenopathy mimicking hyper-IL-6 syndrome. This case can serve as an excellent reminder that the definitive diagnosis of IgG4-RD should be established using a systematic approach, in particular when it appears as an atypical manifestation.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-item>
          <term>CRP</term>
          <def>
            <p>C-reactive protein</p>
          </def>
        </def-item>
        <def-item>
          <term>CT</term>
          <def>
            <p>computed tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>FDG</term>
          <def>
            <p>fluorodeoxyglucose</p>
          </def>
        </def-item>
        <def-item>
          <term>FNAC</term>
          <def>
            <p>fine needle aspiration cytology</p>
          </def>
        </def-item>
        <def-item>
          <term>HHV8</term>
          <def>
            <p>human herpes virus 8</p>
          </def>
        </def-item>
        <def-item>
          <term>HIV</term>
          <def>
            <p>human immunodeficiency virus</p>
          </def>
        </def-item>
        <def-item>
          <term>IgG4-RD</term>
          <def>
            <p>Immunoglobulin G4-related disease</p>
          </def>
        </def-item>
        <def-item>
          <term>MCD</term>
          <def>
            <p>multicentric Castleman&#x2019;s disease</p>
          </def>
        </def-item>
        <def-item>
          <term>MM</term>
          <def>
            <p>multiple myeloma</p>
          </def>
        </def-item>
        <def-item>
          <term>MRI</term>
          <def>
            <p>magnetic resonance imaging</p>
          </def>
        </def-item>
        <def-item>
          <term>PET</term>
          <def>
            <p>positron emission tomography</p>
          </def>
        </def-item>
        <def-item>
          <term>PTGC</term>
          <def>
            <p>progressively transformed germinal center</p>
          </def>
        </def-item>
        <def-item>
          <term>RF</term>
          <def>
            <p>rheumatoid factor</p>
          </def>
        </def-item>
        <def-item>
          <term>SUV</term>
          <def>
            <p>standardized uptake value</p>
          </def>
        </def-item>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>MN, OI, and KT participated in the design of the study and histopathological evaluation, and drafted the manuscript. CT assisted in drafting the manuscript and revised the manuscript. MN, OI, and CT made contributions in analyzing the histopathological characteristics. JK revised the manuscript and gave final approval of the manuscript as professor of the Dental and Oral Medical Center, Kurume University School of Medicine. All authors have given approval for the final version to be published.</p>
      </fn>
    </fn-group>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stone</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Zen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Deshpande</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>IgG4-related disease</article-title>
          <source>N Engl J Med</source>
          <year>2012</year>
          <volume>366</volume>
          <issue>6</issue>
          <fpage>539</fpage>
          <lpage>51</lpage>
          <pub-id pub-id-type="doi">10.1056/NEJMra1104650</pub-id>
          <pub-id pub-id-type="pmid">22316447</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Umehara</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Okazaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Masaki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kawano</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Yamamoto</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Saeki</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011</article-title>
          <source>Mod Rheumatol</source>
          <year>2012</year>
          <volume>22</volume>
          <issue>1</issue>
          <fpage>21</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.3109/s10165-011-0571-z</pub-id>
          <pub-id pub-id-type="pmid">22218969</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <mixed-citation publication-type="other">Pieringer H, Parzer I, W&#xF6;hrer A, Reis P, Oppl B, Zwerina J. IgG4- related disease: an orphan disease with many faces. Orphanet J Rare Dis. 2014; 9(110): doi:10.1186/s13023-014-0110-z.</mixed-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deshpande</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Zen</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Yi</surname>
              <given-names>EE</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yoshino</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Consensus statement on the pathology of IgG4-related disease</article-title>
          <source>Mod Pathol</source>
          <year>2012</year>
          <volume>25</volume>
          <issue>9</issue>
          <fpage>1181</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="doi">10.1038/modpathol.2012.72</pub-id>
          <pub-id pub-id-type="pmid">22596100</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Yoshino</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>IgG4-related lymphadenopathy</article-title>
          <source>Int J Rheumatol</source>
          <year>2012</year>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takata</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Morito</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Mizobuchi</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Tanaka</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Multicentric Castleman's disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases</article-title>
          <source>J Clin Pathol</source>
          <year>2010</year>
          <volume>63</volume>
          <issue>12</issue>
          <fpage>1084</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="doi">10.1136/jcp.2010.082958</pub-id>
          <pub-id pub-id-type="pmid">20974624</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Asano</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Sato</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Rheumatoid lymphadenopathy with abundant IgG4(+) plasma cells : a case mimicking IgG4-related disease</article-title>
          <source>J. Clin. Exp. Hematop.</source>
          <year>2012</year>
          <volume>52</volume>
          <issue>1</issue>
          <fpage>57</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="doi">10.3960/jslrt.52.57</pub-id>
          <pub-id pub-id-type="pmid">22706532</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ferry</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>IgG4-related lymphadenopathy and IgG4-related lymphoma: moving targets</article-title>
          <source>Diagn. Histopathol.</source>
          <year>2013</year>
          <volume>19</volume>
          <issue>4</issue>
          <fpage>128</fpage>
          <lpage>39</lpage>
          <pub-id pub-id-type="doi">10.1016/j.mpdhp.2013.01.005</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bhatti</surname>
              <given-names>RM</given-names>
            </name>
            <name>
              <surname>Stelow</surname>
              <given-names>EB</given-names>
            </name>
          </person-group>
          <article-title>IgG4-related disease of the head and neck</article-title>
          <source>Adv Anat Pathol</source>
          <year>2013</year>
          <volume>20</volume>
          <issue>1</issue>
          <fpage>10</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1097/PAP.0b013e31827b619e</pub-id>
          <pub-id pub-id-type="pmid">23232567</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sato</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kojima</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Takata</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Morito</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Asaoku</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Systemic IgG4-related lymphadenopathy: a clinical and pathologic comparison to multicentric Castleman&#x2019;s disease</article-title>
          <source>Mod Pathol</source>
          <year>2009</year>
          <volume>22</volume>
          <issue>4</issue>
          <fpage>589</fpage>
          <lpage>99</lpage>
          <pub-id pub-id-type="doi">10.1038/modpathol.2009.17</pub-id>
          <pub-id pub-id-type="pmid">19270642</pub-id>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hirano</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Yasukawa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Harada</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Taga</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Watanabe</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Matsuda</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin</article-title>
          <source>Nature</source>
          <year>1986</year>
          <volume>324</volume>
          <issue>6092</issue>
          <fpage>73</fpage>
          <lpage>6</lpage>
          <pub-id pub-id-type="doi">10.1038/324073a0</pub-id>
          <pub-id pub-id-type="pmid">3491322</pub-id>
        </element-citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bandieri</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Luppi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Luppi</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Federico</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sabbatini</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Torelli</surname>
              <given-names>G</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Daily variations of immunoreactive serum interleukin-6 levels in multiple myeloma</article-title>
          <source>Blood</source>
          <year>1995</year>
          <volume>86</volume>
          <issue>2</issue>
          <fpage>832</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="pmid">7606015</pub-id>
        </element-citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dominguez</surname>
              <given-names>RA</given-names>
            </name>
            <name>
              <surname>Abreu</surname>
              <given-names>GP</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>de la Rosa</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vargas</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marrero</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Circadian variations in proinflammatory cytokine concentrations in acute myocardial infarction</article-title>
          <source>Rev Esp Cardiol</source>
          <year>2003</year>
          <volume>56</volume>
          <issue>6</issue>
          <fpage>555</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="doi">10.1016/S0300-8932(03)76916-4</pub-id>
          <pub-id pub-id-type="pmid">12783730</pub-id>
        </element-citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Arvidson</surname>
              <given-names>NG</given-names>
            </name>
            <name>
              <surname>Gudbjornsson</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Elfman</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Ryden</surname>
              <given-names>AC</given-names>
            </name>
            <name>
              <surname>Totterman</surname>
              <given-names>TH</given-names>
            </name>
            <name>
              <surname>Hallgren</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Circadian rhythm of serum interleukin-6 in rheumatoid arthritis</article-title>
          <source>Ann Rheum Dis</source>
          <year>1994</year>
          <volume>53</volume>
          <issue>8</issue>
          <fpage>521</fpage>
          <lpage>24</lpage>
          <pub-id pub-id-type="doi">10.1136/ard.53.8.521</pub-id>
          <pub-id pub-id-type="pmid">7944637</pub-id>
        </element-citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Castleman</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Iverson</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Menendez</surname>
              <given-names>VP</given-names>
            </name>
          </person-group>
          <article-title>Localized mediastinal lymph node hyperplasia resembling thymoa</article-title>
          <source>Cancer</source>
          <year>1956</year>
          <volume>9</volume>
          <issue>4</issue>
          <fpage>822</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="doi">10.1002/1097-0142(195607/08)9:4&lt;822::AID-CNCR2820090430&gt;3.0.CO;2-4</pub-id>
          <pub-id pub-id-type="pmid">13356266</pub-id>
        </element-citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oksenhendler</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Carcelain</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Aoki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Boulanger</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Maillard</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Clauvel</surname>
              <given-names>JP</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients</article-title>
          <source>Blood</source>
          <year>2000</year>
          <volume>96</volume>
          <issue>10</issue>
          <fpage>2069</fpage>
          <lpage>73</lpage>
          <pub-id pub-id-type="pmid">10979949</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
